Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Oncotarget ; 8(60): 101284-101297, 2017 Nov 24.
Article in English | MEDLINE | ID: mdl-29254164

ABSTRACT

Transmembrane 4 L6 family proteins have been known to promote cancer. In this study, we demonstrated that transmembrane 4 L6 family member 4 (TM4SF4), which is induced by γ-radiation in non-small cell lung cancer (NSCLC) cells, is involved in epithelial-to-mesenchymal transition (EMT) and cancer stem cell (CSC) properties of NSCLC through the regulation of osteopontin (OPN). Forced TM4SF4 overexpression in A549 cells increased the secretion of OPN, which activates CD44 or integrin signaling and thus maintains EMT-associated CSC-like properties. OPN, known as a downstream target of ß-catenin/T-cell factor 4 (TCF-4), was induced by up-regulated ß-catenin via TM4SF4-driven phosphorylation of glycogen synthase kinase 3b (GSK3ß). TCF4 complexed to promoter regions of OPN in TM4SF4-overexpressing A549 cells was also confirmed by chromatin immunoprecipitation. Knockout of either ß-catenin or TCF4-suppressed OPN expression, demonstrating that both factors are essential for OPN expression in NSCLC cells. OPN secreted by TM4SF4/GSK3ß/ß-catenin signaling activated the JAK2/STAT3 or FAK/STAT3 pathway, which also up-regulates OPN expression in an autocrine manner and consequently maintains the self-renewal and metastatic capacity of cancer cells. Neutralizing antibody to OPN blocked the autocrine activation of OPN expression, consequently weakened the metastatic and self-renewal capacity of cancer cells. Collectively, our findings indicate that TM4SF4-triggered OPN expression is involved in the persistent reinforcement of EMT or cancer stemness by creating a positive feedback autocrine loop with JAK2/STAT3 or FAK/STAT3 pathways.

2.
Biochem Biophys Res Commun ; 454(3): 369-75, 2014 11 21.
Article in English | MEDLINE | ID: mdl-25451256

ABSTRACT

Fibulin-3 (FBLN-3) has been postulated to be either a tumor suppressor or promoter depending on the cell type, and hypermethylation of the FBLN-3 promoter is often associated with human disease, especially cancer. We report that the promoter region of the FBLN-3 was significantly methylated (>95%) in some pancreatic cancer cell lines and thus FBLN-3 was poorly expressed in pancreatic cancer cell lines such as AsPC-1 and MiaPaCa-2. FBLN-3 overexpression significantly down-regulated the cellular level of c-MET and inhibited hepatocyte growth factor-induced c-MET activation, which were closely associated with γ-radiation resistance of cancer cells. Moreover, we also showed that c-MET suppression or inactivation decreased the cellular level of ALDH1 isozymes (ALDH1A1 or ALDH1A3), which serve as cancer stem cell markers, and subsequently induced inhibition of cell growth in pancreatic cancer cells. Therefore, forced overexpression of FBLN-3 sensitized cells to cytotoxic agents such as γ-radiation and strongly inhibited the stemness and epithelial to mesenchymal transition (EMT) property of pancreatic cancer cells. On the other hand, if FBLN3 was suppressed in FBLN-3-expressing BxPC3 cells, the results were opposite. This study provides the first demonstration that the FBLN-3/c-MET/ALDH1 axis in pancreatic cancer cells partially modulates stemness and EMT as well as sensitization of cells to the detrimental effects of γ-radiation.


Subject(s)
Extracellular Matrix Proteins/genetics , Isoenzymes/genetics , Pancreas/radiation effects , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/radiotherapy , Proto-Oncogene Proteins c-met/genetics , Retinal Dehydrogenase/genetics , Aldehyde Dehydrogenase 1 Family , Amino Acid Sequence , Base Sequence , Cell Line, Tumor , CpG Islands/radiation effects , DNA Methylation/radiation effects , Epithelial-Mesenchymal Transition/radiation effects , Extracellular Matrix Proteins/chemistry , Extracellular Matrix Proteins/metabolism , Gamma Rays , Gene Expression Regulation, Neoplastic/radiation effects , Humans , Isoenzymes/metabolism , Neoplastic Stem Cells/metabolism , Neoplastic Stem Cells/pathology , Neoplastic Stem Cells/radiation effects , Pancreas/metabolism , Pancreas/pathology , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/pathology , Promoter Regions, Genetic/radiation effects , Proto-Oncogene Proteins c-met/metabolism , Retinal Dehydrogenase/metabolism
3.
Biochem Biophys Res Commun ; 443(1): 49-55, 2014 Jan 03.
Article in English | MEDLINE | ID: mdl-24269823

ABSTRACT

Dickkopf1 (DKK1), a secreted protein involved in embryonic development, is a potent inhibitor of the Wnt signaling pathway and has been postulated to be a tumor suppressor or tumor promoter depending on the tumor type. In this study, we showed that DKK1 was expressed differently among non-small-cell lung cancer cell lines. The DKK1 expression level was much higher in A549 cells than in H460 cells. We revealed that blockage of DKK1 expression by silencing RNA in A549 cells caused up-regulation of intracellular reactive oxygen species (ROS) modulator (ROMO1) protein, followed by partial cell death, cell growth inhibition, and loss of epithelial-mesenchymal transition property caused by ROS, and it also increased γ-radiation sensitivity. DKK1 overexpression in H460 significantly inhibited cell survival with the decrease of ROMO1 level, which induced the decrease of cellular ROS. Thereafter, exogenous N-acetylcysteine, an antioxidant, or hydrogen peroxide, a pro-oxidant, partially rescued cells from death and growth inhibition. In each cell line, both overexpression and blockage of DKK1 not only elevated p-RB activation, which led to cell growth arrest, but also inactivated AKT/NF-kB, which increased radiation sensitivity and inhibited cell growth. This study is the first to demonstrate that strict modulation of DKK1 expression in different cell types partially maintains cell survival via tight regulation of the ROS-producing ROMO1 and radiation resistance.


Subject(s)
Intercellular Signaling Peptides and Proteins/physiology , Lung Neoplasms/pathology , Lung Neoplasms/radiotherapy , Membrane Proteins/genetics , Mitochondrial Proteins/genetics , Radiation Tolerance , Cell Line, Tumor , Cell Survival/genetics , Epithelial-Mesenchymal Transition/radiation effects , Gamma Rays , Humans , Intercellular Signaling Peptides and Proteins/genetics , NF-kappa B/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Reactive Oxygen Species/metabolism , Retinoblastoma Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...